Medical Solutions to Buy Geneservice for $7.6M | GenomeWeb
NEW YORK (GenomeWeb News) — Medical Solutions plans to buy Geneservice for ₤3.9 million ($7.6 million), Medical Solutions said in a statement on Thursday.
 
Geneservice, a 2005 spinout of the UK’s Medical Research Council, provides genomics services, such as qPCR, to academic and corporate clients.
 
Medical Solutions said it is looking to expand its diagnostic and prognostic tests, and said it believes qPCR will be “the favored technology” for many diagnostics in five to 10 years.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.